Medscape10h
Despite Price Caps, Some Still Struggle to Access Insulin
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Managed Healthcare Executive7h
FDA Approves First Biosimilar of Novolog
Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...
Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class ...
Factbox-Fat, not muscle: drugmakers in race for next weight-loss breakthrough
The U.S. drugmaker spent nearly $2 billion in 2023 to acquire Versanis Bio's bimagrumab, which prevents the activity of a ...
SHINE10h
China developed diabetes drug highlights biopharma surge
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
No more needles? Startups are testing patches to deliver weight-loss drugs and other medications.
Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.